التفاصيل البيبلوغرافية
| العنوان: |
Management of systemic prostate cancer: current algorithm from castration sensitive to castration resistant setting. |
| المؤلفون: |
D’ANIELLO, C., CAVALIERE, C., FOGLIA, C., FACCHINI, S., URICCHIO, F., BALSAMO, R., FRANZESE, E., DE FALCO, S., IZZO, M., LATERZA, M., LIGUORI, C., COPPOLA, P., DIESSA, Y., FASANO, M., DI LAURO, G., LAI, S., COCETTA, V., PISCONTI, S., MONTESARCHIO, V., FACCHINI, G. |
| المصدر: |
European Review for Medical & Pharmacological Sciences; Nov2022, Vol. 26 Issue 22, p8481-8501, 21p |
| مستخلص: |
In recent years, the advanced knowledge of clinical, biological and molecular features of prostate cancer have led to the introduction of new drugs and have allowed the relocation of old drugs in different settings. In this way, the new concepts of systemic disease arise: high risk or high volume vs. low risk and low volume disease castration sensitive prostate cancer (CSPC), diversifying the use of previously approved drugs (CRPC) and opening new scenarios for sequence therapy. The aim of this review is to integrate new developments into the medical management of systemic prostate cancer. [ABSTRACT FROM AUTHOR] |
|
Copyright of European Review for Medical & Pharmacological Sciences is the property of Verduci Editore and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Supplemental Index |
